In growing numbers funding agencies are recognizing that many of our citizens are affected by violence in their own homes. This has led to increasing support for programs which seek to prevent and treat domestic violence. Several programs affiliated with the Bureau have enhanced such activity recently:

Hospital Crisis Intervention Project: Domestic Violence Research and Intervention

The Hospital Crisis Intervention Project (HCIP), the on-site domestic violence training and advocacy program at Cook County Hospital, has been providing direct services to victims of abuse and training clinicians on domestic violence since 1993. Over the last couple of years, HCIP has increasingly worked on research, training and policy initiatives on local and national levels.

In its current research activities, HCIP's co-directors, Carole Warshaw, MD, and Kim Riordan, serve on the advisory board of the Women's Health Risk Study, a collaborative project headed by Carolyn Rebecca Block, Ph.D., of the Illinois Criminal Justice Information Authority. A major goal of the study is to identify factors that place women at high risk for serious injury or death in situations in which she is being abused by an intimate partner. Cook County Hospital has been a major site for the study, particularly within the Department of Trauma, the Ambulatory Screening Clinic, OB/GYN Clinic, and HCIP. A substantial number of the 1,695 women who were interviewed for the study came from CCH. Preliminary data has revealed marked differences in the experiences of abused and the control group of non-abused women. 

For example, 70% of abused women reported that an intimate partner tried to limit her contact with family or friends compared to 21% of non-abused women; 45% of abused women reported that their intimate partner threatened to kill her if she left the relationship, versus 8% of non-abused women. 

Recently, Dr. Warshaw was awarded a two-year grant of $100,00 from the Chicago Community Trust to begin a Domestic Violence and Mental Health Policy and Training Initiative, a collaborative project designed to address the barriers that domestic violence advocates and mental health providers face in serving victims of abuse. While it has long been recognized that victimization by an intimate partner has serious psychological consequences, collaborative models for addressing these issues have been slow to develop. The initiative is designed to improve services for women who have both mental health and advocacy needs--needs that often go unmet when addressed by either system alone. 

Over the course of two years, the project will convene intra- and interdisciplinary meetings of advocates, substance abuse providers, survivors of abuse, and mental health clinicians to conduct a needs assessment and to develop a strategic plan to foster collaborative models for service delivery and cross-trainings. The Chicago Department of Public Health will be a collaborating partner and will involve key department directors as well as practitioners from local mental health clinics.

In addition to this project, Dr. Warshaw was awarded $10,000 from the Research Infrastructure Support Program of the University of Illinois at Chicago's Department of Psychiatry to conduct a qualitative study of women's perceived mental health needs as a result of abuse and their utilization of and satisfaction with health, mental health, and community-based supports and services. The study is designed to generate preliminary qualitative data to develop a culturally relevant instrument to assess the experiences of diverse groups of women. 

HCIP is a collaborative effort of the Cook County Bureau of Health Services and the Chicago Abused Women Coalition (CAWC), the oldest domestic violence agency in the city. The first program of its kind to be located in a public hospital, HCIP has been hailed as a national model for hospital-based domestic violence programming. 

HCIP was one of ten programs around the country to be featured in a manual produced by the Family Violence Prevention Fund entitled, "Best Practices: Innovative Domestic Violence Programs in Hospital Settings," and was recently highlighted in Empowering Survivors of Abuse: Health Care for Battered Women and their Children, published by Sage. To contact HCIP, please call Kim Riordan at 312-633-5992. 
 

Department of Emergency Medicine: Case Identification and Followup

The Illinois Violence Prevention Authority recently funded a project directed by Dr. Helen Straus of the CCH Emergency Medicine Department. The objective of this project is to establish empirical evidence about domestic violence patients likely to benefit from Hospital Emergency Department case identification and referral to hospital crisis and community-based intervention sites. 

This is a longitudinal cross-sectional study of 100 patients identified as domestic violence victims in the Emergency Department. The effects of their use of community services and intermediate outcomes on their reported quality of life at will be studied 1 and 3 months after enrollment.

The study is expected to provide: 
1) A description of the natural history of domestic violence over a 3-month course and its relationship to baseline characteristics and use of intervention services; 
2) A comparison of baseline survey measures in victims against a random sample of never-victimized control patients; 
3) Increased ability to predict patients' use of resources and outcomes using such baseline characteristics; 
4) A determination of the frequency of use and effectiveness of intervention services to assist in policy decisions for allocating resources. 

The information gained will, it is hoped, improve domestic violence case identification, use of specialty services, and patient outcomes.
 

On November 9, the Department of Health and Human Services issued new criteria for projects that are eligible for review by an expedited process. An Expedited Review is a review of the proposed research by the Scientific Committee chair or a designated voting member, or group of voting members, rather than by the entire Scientific Committee. Having your project reviewed this way can speed up the IRB approval process. Federal rules permit expedited review for certain kinds of research involving no more than minimal risk and for minor changes in approved research.

A risk is minimal where the probability and magnitude of harm or discomfort anticipated in the proposed research are not greater, in and of themselves, than those ordinarily encountered in daily life or during the performance of routine physical or psychological examinations or tests. For instance, the risk of drawing a small amount of blood from a healthy individual for research purposes is no greater than the risk of doing so as part of a routine physical examination.

The following table summarizes the ways in which research which may be eligible for expedited review:

Applicability: The IRB may use the expedited review procedure for research activities that: 

(1) present no more than minimal risk to human subjects, and

(2) involve only procedures listed in one or more of the following categories (listed under "Research Categories")

An activity is not deemed to be of minimal risk simply because it is on this list. Inclusion on the list means only that the activity is eligible for expedited review. The determination will be made based on whether the project poses no more than minimal risk to subjects.

The categories in this list apply regardless of the age of subjects, except as noted.

The expedited review procedure may not be used where identification of the subjects and/or their responses would reasonably place them at risk of criminal or civil liability or be damaging to the subjects' financial standing, employability, insurability, reputation, or be stigmatizing, unless reasonable and appropriate protections will be implemented so that risks related to invasion of privacy and breach of confidentiality are no greater than minimal.

The standard requirements for informed consent apply regardless of the type of review--expedited or full--used by the IRB.

Categories one (1) through seven (7) pertain to both initial and continuing IRB review (progress reports)
 

Research Categories   (1) Clinical studies of drugs and medical devices only when condition (a) or (b) is met. (a) Research on drugs for which an investigational new drug application (21 CFR Part 312) is not required. (Note: Research on marketed drugs that significantly increases the risks or decreases the acceptability of the risks associated with the use of the product is not eligible for expedited review.) (b) Research on medical devices for which (i) an investigational device exemption application (21 CFR Part 812) is not required; or (ii) the medical device is cleared/approved for marketing and the medical device is being used in accordance with its cleared/approved labeling.   (2) Collection of blood samples by finger stick, heel stick, ear stick, or venipuncture as follows: (a) From healthy, nonpregnant adults who weigh at least 110 pounds. For these subjects, the amounts drawn may not exceed 550 ml in an 8 week period and collection may not occur more frequently than 2 times per week; or (b) from other adults and children2, considering the age, weight, and health of the subjects, the collection procedure, the amount of blood to be collected, the frequency with which it will be collected. For these subjects, the amount drawn may not exceed the lesser of 50 ml or 3 ml per kg in an 8 week period and collection may not occur more frequently than 2 times per week. ------------------------------------------------------------------------------------------- 2Children are defined in the HHS regulations as ``persons who have not attained the legal age for consent to treatments or procedures involved in the research, under the applicable law of the jurisdiction in which the research will be conducted.''     (3) Prospective collection of biological specimens for research purposes by noninvasive means. Examples:  (a) hair and nail clippings in a nondisfiguring manner; (b) deciduous teeth at time of exfoliation or if routine care indicates a need for extraction;  (c) permanent teeth if routine patient care indicates a need for extraction;  (d) excreta and external secretions (including sweat);  (e) uncannulated saliva collected either in an unstimulated fashion or stimulated by chewing gumbase or wax or by applying a dilute citric solution to the tongue;  (f) placenta removed at delivery;  (g) amniotic fluid obtained at the time of rupture of the membrane prior to or during labor;  (h) supra- and subgingival dental plaque and calculus, provided the collection procedure is not more invasive than routine prophylatic scaling of the teeth and the process is accomplished in accordance with accepted prophylactic techniques;  (i) mucosal and skin cells collected by buccal scraping or swab, skin swab, or mouth washings;  (j) sputum collected after saline mist nebulization.       (4) Collection of data through noninvasive procedures (not involving general anesthesia or sedation) routinely employed in clinical practice, excluding procedures involving x-rays or microwaves. Where medical devices are employed, they must be cleared/approved for marketing. (Studies intended to evaluate the safety and effectiveness of the medical device are not generally eligible for expedited review, including studies of cleared medical devices for new indications.) Examples:  (a) physical sensors that are applied either to the surface of the body or at a distance and do not involve input of significant amounts of energy into the subject or an invasion of the subject's privacy;  (b) weighing or testing sensory acuity;  (c) magnetic resonance imaging;  (d) electrocardiography, electroencephalography, thermography, detection of naturally occurring radioactivity, electroretinography, ultrasound, diagnostic infrared imaging, doppler blood flow, and echocardiography; (e) moderate exercise, muscular strength testing, body composition assessment, and flexibility testing where appropriate given the age, weight, and health of the individual.     (5) Research involving materials (data, documents, records, or specimens) that have been collected or will be collected solely for nonresearch purposes (such as medical treatment or diagnosis). [Note: Some research in this category may qualify for an exemption from IRB review. Major criteria to qualify for exemption with this kind of research would be compiling the data retrospectively and removing personal identifiers]     (6) Collection of data from voice, video, digital, or image recordings made for research purposes.   (7) Research on individual or group characteristics or behavior (including, but not limited to, research on perception, cognition, motivation, identity, language, communication, cultural beliefs or practices, and social behavior) or research employing survey, interview, oral history, focus group, program evaluation, human factors evaluation, or quality assurance methodologies. [Note: Some research in this category may qualify for an exemption from IRB review. This kind of research most often can be exempted when: 1) the subjects are competent, non-incarcerated adults; and 2) the data gathering process does not pose more than minimal risk to subjects]   (8) Continuing review of research previously approved by the convened IRB as follows: (a) Where  (i) the research is permanently closed to the enrollment of new subjects;  (ii) all subjects have completed all research-related interventions; and  (iii) the research remains active only for long-term follow-up of subjects; or (b) Where no subjects have been enrolled and no additional risks have been identified; or (c) Where the remaining research activities are limited to data analysis.     (9) Continuing review of research, not conducted under an investigational new drug application or investigational device exemption where categories two (2) through eight (8) do not apply but the IRB has determined and documented at a convened meeting that the research involves no greater than minimal risk and no additional risks have been identified.

The Association for Health Services Research has issued a call for abstracts to be presented at its 16th Annual Meeting in Chicago in June. The deadline for submission is January 15, 1999. For more information call 202-223-2477 or go to http://www.ahsr.org.
 

Back to top

[A long-term calendar showing most of the major academic medical society meetings can be found on the web at: http://www.aamc.org/meetings/mjmtgcal.htm] 

Making Change Happen: Finding Common Ground, the 13th Annual Maternal and Child health Leadership Conference, sponsored by Regions V and VII of the Department of Health and Human Services, will be held April 24-27 in Chicago. For more information call 312-996-0724.

Research Involving Infants, Children & Adolescents: Issues and Ethis for the 21st Century is a conference to be held April 21-23 in Kansas City, MO. The meeting will be sponsored by the Office for Prevention from Research Risks and the Food and Drug Administration; for more information call 913-345-1990, or go to http://www.childrens-mercy-org/foprr1.htm.

Options in Health Science Education will be offered by the University of New Mexico School of Medicine, February 7-12, in Albuquerque, NM. For more information call 505-272-3942.

Professional Competence and Board Certification, offered by the American Board of Medical Specialties on March 18-19 in Chicago. Call 847-491-9091 for information.

Introductory Workshop for Institutional Misconduct Officials, sponsored by the Office of Research Integrity and the University of California at San Diego, will be held February 18 in La Jolla, CA. For information call 800-711-5030.

Research Integrity A Professional, Ethical, and Social Obligation will take place March 11-12 in Houston, cosponsored by the Office of research Integrity and the University of Texas-Houston Health Science Center. Call 713-500-2028 for more information.

Authorship Retreat, cosponsored by the Office of Research Integrity and the Council of Biology editors, will take place in Montreal May 24. Call 215-351-2620 for information.

Teaching Research Ethics Sixth Annual Workshop, will be offered in Bloomington, IN May 26-29, sponsored by Indiana University, Michigan State University, University of Illinois, University of Michigan and the University of Minnesota. Call 812-855-0261 for more information.
 
 

Office of Research Development Workshops 

These workshops are open to any County-affiliated investigator or grant-seeker. Enrollment for some sessions is limited, so please register only for those you will be able to attend. 

Grant Writing Seminar:

Gives an overview of the entire process of developing a project and applying for funding. Includes information on approaching both governmental and private funders, describes an approach to developing grant budgets, discusses stylistic and content issues that are frequent stumbling blocks in writing grant applications.

Constructing a Grant Budget:

Covers many of the technical aspects of developing an accurate time line and budget for a grant proposal.

What Are All These Forms? Interacting With the Scientific Committee: 

Gives an orientation to procedures -- and the associated forms -- used by the Scientific Committee to 
ensure that patients are protected from undue risks in research. The Bureau forms will be discussed, and new policies and changes in federal regulations will be covered.

To register for any of these, call Bennetta Anderson at 312-633-4941. If you would like to schedule one or more of these workshops in your Department or at another site, please call Karen Smith at 633-4940. 
 
 
 
 

Back to top
 
 
 

To have the NIH Guide sent automatically to your e-mail address every week, click on the LISTSERV link on this page and follow the instructions.

To ask specific questions about NIH grant programs, send e-mail to: grantsinfo@nih.gov 
 

These are one time only opportunities. Call 312-633-4940 to check for due dates or to get copies of full announcements

Back to top

NINR CAREER TRANSITION AWARD
(RFA NR-99-002) National Institute of Nursing Research

NEW ANTIPSYCHOTIC DRUG TRIALS (RFP NIMH-99-DS-001) National Institute of Mental Health

TRANSDISCIPLINARY TOBACCO USE RESEARCH CENTERS (RFA CA-98-029)
National Cancer Institute, National Institute on Drug Abuse

CLINICAL CENTERS FOR PRELIMINARY STUDIES ON RETINOIC ACID TREATMENT IN EMPHYSEMA (RFP NHLBI-HR-99-01)
National Heart, Lung, and Blood Institute

ABDOMINAL AORTIC ANEURYSM: PATHOGENESIS (RFA HL-99-007) National Heart, Lung, and Blood Institute

TECHNOLOGIES FOR GENE EXPRESSION ANALYSIS IN THE NERVOUS SYSTEM
(RFA NS-99-003) National Institute of Neurological Disorders and Stroke; National Institute of Mental Health; National Center for Research Resources; National Eye Institute; National Human Genome Research Institute; National Institute on Alcohol Abuse and Alcoholism; National Institute on Aging; 
National Institute of Child Health and Human Development; National Institute on Deafness and Other Communication Disorders; National Institute on Drug Abuse; National Institute of Environmental Health Sciences

EDUCATIONAL WORKSHOPS IN INTERDISCIPLINARY RESEARCH
(RFA OD-99-004) National Institute of Nursing Research; National Institute of Child Health and Human Development; National Institute of Dental and Craniofacial Research; National Institute on Aging; Office of Behavioral and Social Sciences Research

ANALYTICAL CHEMISTRY AND STABILITY TESTING OF TREATMENT DRUGS (RFP N01DA-9-8093) National Institute on Drug Abuse

TREATMENT RESISTANT DEPRESSION (RFP NIMH-99-DS-0003) National Institute of Mental Health

PLANNING GRANTS FOR MULTIPURPOSE CLINICAL RESEARCH CENTERS (RFA AR-99-002) National Institute of Arthritis and Musculoskeletal and Skin Diseases
 

HUMAN ISLET TRANSPLANTATION INTO HUMANS (RFA DK-99-006) National Institute of Diabetes and Digestive and Kidney Diseases;
National Institute of Allergy and Infectious Diseases; Juvenile Diabetes Foundation International

FUNCTIONAL GENOMICS OF THE DEVELOPING ENDOCRINE PANCREAS
(RFA DK-99-007) National Institute of Diabetes and Digestive and Kidney Diseases

TUBERCULOSIS DRUG DEVELOPMENT: TUBERCULOSIS ANTI-MICROBIAL ACQUISITION AND COORDINATING FACILITY (RFP NIH-NIAID-DAIDS-99-05)
National Institute of Allergy and Infectious Diseases

TUBERCULOSIS DRUG DEVELOPMENT: TUBERCULOSIS TECHNOLOGY TRANSFER
SUPPORT (RFP NIH-NIAID-DAIDS-99-17)
National Institute of Allergy and Infectious Diseases

PREVENTING FETAL ALCOHOL SYNDROME (FAS) (RFA AA-99-002) National Institute on Alcohol Abuse and Alcoholism; Office of Research on Women's Health

STUDY OF HEALTH OUTCOMES OF WEIGHT-LOSS (SHOW) (RFA DK-98-019)
National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of Environmental Health Sciences; National Heart, Lung, and Blood Institute; National Institute of Nursing Research; Office of Research on Women's Health; Centers for Disease Control and Prevention

STUDY OF HEALTH OUTCOMES OF WEIGHT-LOSS (SHOW): DATA COORDINATING CENTER (RFA DK-98-020) National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of Environmental Health Sciences; National Heart, Lung, and Blood Institute; National Institute of Nursing Research; Office of Research on Women's Health; Centers for Disease Control and Prevention

SUPERFUND HAZARDOUS SUBSTANCES BASIC RESEARCH PROGRAM (RFA ES-99-001) National Institute of Environmental Health Sciences

RESEARCH CAREER DEVELOPMENT IN MENTAL DISORDERS OF CHILDREN
(RFA MH-99-002) National Institute of Mental Health

MOLECULAR GENETICS OF SCHIZOPHRENIA AND DEPRESSION (RFA MH-99-005) National Institute of Mental Health

AIRWAY REMODELING AND REPAIR IN ASTHMA (RFA HL-99-005) National Heart, Lung, and Blood Institute

HPA REGULATION: CROSS-DISCIPLINARY RESEARCH NETWORKS (RFA MH-99-003)
National Institute of Mental Health

PREVENTION OF ALCOHOL-RELATED PROBLEMS AMONG COLLEGE STUDENTS
(RFA AA-99-001) National Institute on Alcohol Abuse and Alcoholism; SAMHSA Center for Substance Abuse Prevention; Department of Education

NEUROBIOLOGICAL MECHANISMS OF ADOLESCENT ALCOHOL ABUSE (RFA AA-99-003) National Institute on Alcohol Abuse and Alcoholism

XENOBIOTICS AND NEURODEVELOPMENTAL ABNORMALITIES (RFA ES-99-002) National Institute of Environmental Health Sciences

THE NCI SCHOLARS PROGRAM (RFA CA-98-026) National Cancer Institute

WOMEN'S REPRODUCTIVE HEALTH RESEARCH CAREER CENTERS
(RFA HD-99-001) National Institute of Child Health and Human Development; Office of Research on Women's Health
 

Back to top

NIH PROGRAM ANNOUNCEMENTS 
(PA'S): These are ongoing funding priorities, with due dates usually October 1, February 1 and June 1 of each year. Note that HIV-related applications are due January 2, May 1 and September. Past PA's, many of which are still open, can be searched at the NIH Guide web site.

MECHANISMS UNDERLYING INDIVIDUAL VARIATIONS IN DRUG RESPONSES
(PA-99-016) National Institute of General Medical Sciences; National Cancer Institute; National Heart, Lung, and Blood Institute; National Institute of Child Health and Human Development; National Institute of Environmental Health Sciences; National Institute of Mental Health; National Institute on Aging; National Institute on Alcohol Abuse and Alcoholism

NATIONAL RESEARCH SERVICE AWARDS FOR INDIVIDUAL PREDOCTORAL
FELLOWSHIPS (PA-99-017) National Institute of Mental Health; National Institute on Drug Abuse; National Institute on Alcohol Abuse and Alcoholism

NIH NATIONAL RESEARCH SERVICE AWARDS FOR INDIVIDUAL POSTDOCTORAL FELLOWS (F32) (PA-99-025) National Institutes of Health

JOINTLY SPONSORED NIH PREDOCTORAL TRAINING PROGRAM IN THE
NEUROSCIENCES (PAR-97-007) National Institute on Aging; National Institute of Child Health and Human Development; National Institute on Deafness and Other Communication Disorders; National Institute of Dental and Craniofacial Research; National Institute of General Medical Sciences; National Institute of Mental Health; National Institute of Neurological Disorders and Stroke; National Institute of Nursing Research

ECONOMIC STUDIES IN CANCER PREVENTION, SCREENING AND CARE
(PA-99-014) National Cancer Institute; Agency for Health Care Policy and Research; National Institute of Dental and Craniofacial Research

CHIROPRACTIC AND OSTEOPATHIC CLINICAL TRIAL PILOT GRANTS (PA-99-013) National Center for Complementary and Alternative Medicine; National Institute of Arthritis and Musculoskeletal and Skin Disorders; National Institute of Child Health and Human Development

EFFECTIVENESS OF STRATEGIES FOR PREVENTING DUI RECIDIVISM (PAS-99-023) National Institute on Alcohol Abuse and Alcoholism; National Highway Traffic Safety Administration, Department of Transportation; Center for Substance Abuse Treatment, SAMHSA

RESEARCH ON TISSUE ENGINEERING
(PA-99-024) National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institute on Aging; National Institute for Child Health and Human Development; National Institute of Dental and Craniofacial Research; National Institute on Deafness and Other Communication Disorders; National Institute of Diabetes, Digestive, and Kidney Diseases; National Institute of General Medical Sciences; National Institute of Mental Health; National Institute of Neurological Disorders and Stroke; National Heart, Lung, and Blood Institute; National Center for Research Resources

SMALL GRANT PROGRAM FOR THE NIDCD
(PAR-99-018) National Institute on Deafness and Other Communication Disorders

NON-MAMMALIAN ORGANISMS AS MODELS FOR ANTICANCER DRUG DISCOVERY (PAR-99-019) National Cancer Institute

NON-MAMMALIAN ORGANISMS AS MODELS FOR ANTICANCER DRUG DISCOVERY: SBIR/STTR INITIATIVE
(PAR-99-020) National Cancer Institute

BIOBEHAVIORAL PAIN RESEARCH
(PA-99-021) National Institute of Nursing Research; National Institute of Dental and Craniofacial Research; National Institute on Aging; National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Cancer Institute; 
National Institute of Child Health and Human Development; National Institute on Drug Abuse;
National Heart, Lung, and Blood Institute; 
National Institute of Mental Health; National Institute of Neurological Disorders and Stroke; National Center for Complementary and Alternative Medicine

GENOME SCHOLAR DEVELOPMENT AND FACULTY TRANSITION AWARD (PAR-99-022) National Human Genome Research Institute

CANCER SURVEILLANCE USING HEALTH CLAIMS-BASED DATA SYSTEM (PA-99-015)
National Cancer Institute; National Institute of Dental and Craniofacial Research; Agency for Health Care Policy and Research

SPECIAL EMPHASIS RESEARCH CAREER AWARD IN PATHOLOGY AND COMPARATIVE MEDICINE National Center for Research Resources
 

March 2
ENERGY SMALL BUSINESS INNOVATION RESEARCH , Department of Energy (301-903-1414 or http://www.sbir.er.doe.gov/sbir)

April 30
REHABILITATION FOR CHILDREN, Department of Education (202-205-5880, refer to CFDA 84.133B)

January 15
ARTHRITIS RESEARCH, Arthritis National Research Foundation (http://www.curearthritis.org/grant.htm)

February 1
DECISIONMAKING AND VALUATION FOR ENVIRONMENTAL POLICY, Environmental Protection Agency & National Science Foundation (202-564-6849 or http://www.nsf.gov)

February 1
REHABILITATION FOR MINORITY PERSONS WITH DISABILITIES, Department of Education (202-205-5880 or http://ocfo.gov/fedreg.htm)

February 1
HEALTH AND WELLNESS FOR PERSONS WITH LONG-TERM DISABILITIES, Department of Education (202-205-5880 or http://ocfo.gov/fedreg.htm)
 
 

January 15 (Letter of Intent)
AGING RESEARCH, AARP Andrus Foundation (202-434-6190 or http://www.andrus.org)

February 18
ENVIRONMENTAL INVESTIGATOR-INITIATED AWARDS: URBAN AIR TOXICS, Environmental Protection Agency (800-490-9194 or http://www.epa.gov/ncerqa)

February 4
ENVIRONMENTAL INVESTIGATOR-INITIATED AWARDS: ECOLOGICAL INDICATORS AND MERCURY TRANSPORT, Environmental Protection Agency (800-490-9194 or http://www.epa.gov/ncerqa)

April 1 and October 1
DRUG POLICY EDUCATION, Drug Policy Foundation (202-537-5005 or http://www.dpf.org)

Open
NATIONAL HEALTHCARE ISSUES, Baxter Allegiance Foundation (847-948-4605)

January 20
LIMB LOSS RESEARCH, Centers for Disease Control (888-GRANTS4, refer to announcement 99-009, or http://www.cdc.gov)

Open
INVESTIGATOR-INITIATED ENERGY RESEARCH, Department of Energy (301-903-5212, refer to Notice 99-01, or http://www.er.doe.gov/productiongrants/grants.html)

Open
COMPUTERS FOR PEOPLE WITH DISABILITIES, National Cristina Foundation, 800-274-7846 or http://www.cristina.org)

March 1 and March 15
MASSAGE THERAPY-RESEARCH AND COMMUNITY GRANTS, American Massage Therapy Association (847-864-0123 or http://www.amtamassage.org)
 

March 31 (Letter of Intent)
BIRTH DEFECTS RESEARCH, March of Dimes Birth Defects Foundation (914-997-4646 or http://www.modimes.org)

May 31 (Nomination) 
BASIL O'CONNOR STARTER SCHOLAR RESEARCH AWARD, March of Dimes Birth Defects Foundation (914-997-4646 or http://www.modimes.org)

January 21 and February 26
STUDENT SCHOLARSHIPS IN AGING AND GERIATRIC PHARMACOLOGY, American Federation for Aging Research (212-752-2327 or http://www.afar.org)

February 1
STRENGTHENING THE PATIENT-PROVIDER RELATIONSHIP, Robert Wood Johnson (415-502-8275 or http://www.rwjf.org)

February 15
LEUKEMIA RESEARCH, Leukemia Society of America (212-450-8843 or http://www.leukemia.org)

LOST A LINK? 
Look in the alphabetical index to links on this site